{"id":"https://openalex.org/W2806665561","doi":"https://doi.org/10.1056/nejme1806130","title":"Endocrine Adjuvant Therapy for Localized Breast Cancer","display_name":"Endocrine Adjuvant Therapy for Localized Breast Cancer","publication_year":2018,"publication_date":"2018-06-04","ids":{"openalex":"https://openalex.org/W2806665561","doi":"https://doi.org/10.1056/nejme1806130","mag":"2806665561","pmid":"https://pubmed.ncbi.nlm.nih.gov/29863436"},"language":"en","primary_location":{"id":"doi:10.1056/nejme1806130","doi":"https://doi.org/10.1056/nejme1806130","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejme1806130","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028539104","display_name":"Marc E. Lippman","orcid":"https://orcid.org/0000-0001-5280-4084","observed_orcids":["https://orcid.org/0000-0001-5280-4084"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marc E. Lippman","raw_affiliation_strings":["From the University of Miami Miller School of Medicine, Miami","University of Miami Miller School of Medicine, Miami"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Miami Miller School of Medicine, Miami","institution_ids":["https://openalex.org/I145608581"]},{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami","institution_ids":["https://openalex.org/I145608581"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5028539104"],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"379","issue":"2","first_page":"193","last_page":"194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/localized-breast-cancer","display_name":"localized breast cancer","score":0.8489999771118164},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/soft-trial","display_name":"SOFT trial","score":0.9110000133514404},{"id":"https://openalex.org/keywords/text-trial","display_name":"TEXT trial","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ovarian-function-suppression","display_name":"ovarian suppression","score":0.8450000286102295},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.847000002861023},{"id":"https://openalex.org/keywords/exemestane","display_name":"exemestane","score":0.984000027179718},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9449999928474426},{"id":"https://openalex.org/keywords/premenopausal-women","display_name":"premenopausal women","score":0.9549999833106995}],"concepts":[{"id":"https://openalex.org/C2775860665","wikidata":"https://www.wikidata.org/wiki/Q418819","display_name":"Exemestane","level":5,"score":0.9697814583778381},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9028821587562561},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8828197717666626},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7321744561195374},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.703689455986023},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.6365817189216614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6007440686225891},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.5964459776878357},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.5922977328300476},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.5210422873497009},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.46901649236679077},{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.459620863199234},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42630690336227417},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.40172654390335083},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3724345266819},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.16165846586227417}],"mesh":[{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejme1806130","doi":"https://doi.org/10.1056/nejme1806130","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejme1806130","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:29863436","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29863436","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W2067962376","https://openalex.org/W2138691465","https://openalex.org/W2806866264"],"related_works":["https://openalex.org/W4392295077","https://openalex.org/W2103498127","https://openalex.org/W2233558058","https://openalex.org/W2925739042","https://openalex.org/W4311018682","https://openalex.org/W2337488382","https://openalex.org/W2093802928","https://openalex.org/W1912698837","https://openalex.org/W2592968027","https://openalex.org/W2324128800"],"abstract_inverted_index":{"Investigators":[0],"now":[1],"report":[2],"in":[3,16,43,53,81],"the":[4,6,48,64,71,89,92],"Journal":[5],"updated":[7],"results":[8,65],"of":[9,13,23,62,73,91],"two":[10],"critical":[11],"trials":[12],"endocrine":[14],"therapy":[15],"early-stage":[17],"breast":[18],"cancer":[19],"\u2014":[20,33],"SOFT":[21],"(Suppression":[22],"Ovarian":[24],"Function":[25],"Trial)":[26,32],"and":[27,30,88],"TEXT":[28],"(Tamoxifen":[29],"Exemestane":[31],"with":[34],"overlapping":[35],"groups":[36],"that":[37],"permitted":[38],"a":[39],"combined":[40],"analysis.1":[41],"As":[42],"many":[44],"other":[45],"endocrine-therapy":[46],"trials,":[47],"effects":[49],"were":[50],"not":[51],"apparent":[52],"earlier":[54],"analyses,":[55],"but":[56],"after":[57],"8":[58],"to":[59,76,96],"9":[60],"years":[61],"follow-up,":[63],"are":[66],"clear.":[67],"In":[68],"premenopausal":[69],"women,":[70],"addition":[72,90],"ovarian":[74,97],"suppression":[75,98],"tamoxifen":[77,86],"was":[78,99],"more":[79],"effective":[80],"increasing":[82],"disease-free":[83],"survival":[84],"than":[85],"alone,":[87],"aromatase":[93],"inhibitor":[94],"exemestane":[95],".":[100,101,102]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-13T00:00:00"}